<?xml version="1.0" encoding="UTF-8"?><add><doc><field name="id">0003404</field><field name="title">[LMED] SELLS CONVERTIBLE DEBENTURES</field><field name="place">NEW YORK</field><field name="date">March 13</field><field name="content">- LyphoMed Inc is raising 70 mln dlrs through an offering of convertible subordinatred debentures due 2012 with a 5-1/2 pct coupon and par pricing, said lead manager Alex Brown and Sons Inc.     The debentures are convertible into the company's common stock at 36.25 dlrs per share, representing a premium of 27.75 pct over the stock price when terms on the debt were set.     Non-callable for two years, the issue is rated BB by Standard and Poor's Corp. Montgomery Securities co-managed the deal. </field></doc></add>